Histone Deacetylase Inhibitors and Neurodegenerative Disorders: Holding the Promise

E-ISSN： 1873-4286|15|34|3940-3957

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.15, Iss.34, 2009-12, pp. : 3940-3957

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Histone deacetylase inhibitors: possible implications for neurodegenerative disorders

By Hahnen Eric Hauke Jan Tränkle Christian Eyüpoglu Ilker Y Wirth Brunhilde Blümcke Ingmar

Expert Opinion on Investigational Drugs, Vol. 17, Iss. 2, 2008-02 ,pp. : 169-184

Informa Healthcare

Access to resources Recommend Favorite

Histone Deacetylase Inhibitors: New Promise in the Treatment of Immune and Inflammatory Diseases

Current Drug Targets, Vol. 11, Iss. 11, 2010-11 ,pp. : 1430-1438

Bentham Science Publishers

Access to resources Recommend Favorite

Histone deacetylase inhibitors

By Price Steve Dyke Hazel J

Expert Opinion on Therapeutic Patents, Vol. 17, Iss. 7, 2007-07 ,pp. : 745-765

Informa Healthcare

Access to resources Recommend Favorite

Macrocyclic Histone Deacetylase Inhibitors

Current Topics in Medicinal Chemistry, Vol. 10, Iss. 14, 2010-10 ,pp. : 1423-1440

Bentham Science Publishers

Access to resources Recommend Favorite

Histone Deacetylase Inhibitors in Psoriasis Therapy

Current Drug Targets. Inflammation & Allergy, Vol. 3, Iss. 2, 2004-06 ,pp. : 213-219

Bentham Science Publishers

Access to resources Recommend Favorite